Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.42K Buy
+28
New +$2.33K ﹤0.01% 730
2022
Q2
– Sell
-7,604
Closed -$973K – 198
2022
Q1
$973K Sell
7,604
-412
-5% -$45.1K 0.15% 118
2021
Q4
$1.08M Buy
8,016
+128
+2% +$18.4K 0.15% 135
2021
Q3
$1.08M Buy
+7,888
New +$995K 0.16% 129
2018
Q4
– Sell
-12,756
Closed -$456K – 103
2018
Q3
$456K Buy
+12,756
New +$395K 0.19% 106

Other funds holding DXCM

BFSG LLC's DXCM Position: Q3 2026 in Review

BFSG LLC opened a new position in DexCom (DXCM) in Q3 2026: 28 shares worth $2.42K. The stake represents ﹤0.01% of the portfolio and ranks #730 among its holdings. This is a return to the name: BFSG LLC previously reported a position in DXCM as recently as Q1 2022.

BFSG LLC first reported a position in DXCM in Q3 2018 and has held it in 5 quarters since. The position peaked at $1.08M in Q3 2021. 358 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • BFSG LLC held 28 shares of DexCom worth $2.42K as of Q3 2026.
  • DexCom was a new BFSG LLC position in Q3 2026.
  • DexCom made up ﹤0.01% of BFSG LLC's portfolio in Q3 2026, its #730 holding.
  • BFSG LLC first reported a position in DexCom in Q3 2018 and has held it in 5 quarters since.
  • BFSG LLC's DexCom position peaked at $1.08M in Q3 2021.
  • 358 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on BFSG LLC's 13F filing for Q3 2026, filed 30 Oct 2026.